0.5950USD0.00%Mkt Cap: 3.29M $P/E: 1.562d ago
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology …
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.74BUSDP/E 19.8
$20.14BUSD
$17.18BUSDP/E 26.3
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.90BUSD
$9.04BUSDP/E 23.0
$7.60BUSD
$7.11BUSDP/E 470.2
$7.00BUSDP/E 25.7
$5.70BUSDP/E 48.2
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.79BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.36BUSDP/E 12.8
$2.36BUSD
$1.90BUSDP/E 19.2
$1.97BUSD
$1.80BUSDP/E 20.3
$1.84BUSD
$1.74BUSD
$1.57BUSD
$1.48BUSDP/E 17.5
$1.52BUSDP/E 125.7
$1.35BUSDP/E 14.3
$1.21BUSDP/E 38.0
$1.17BUSDP/E 17.5
$1.16BUSD
$1.20BUSD
$1.07BUSDP/E Infinity
$1.01BUSD
$1.01BUSDP/E 197.0
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$870.61MUSDP/E 11.9
$819.46MUSDP/E Infinity
$664.05MUSD
$702.13MUSDP/E 163.7
$635.41MUSDP/E 6.2
$503.88MUSDP/E 14.2
$516.92MUSD
$463.93MUSD
$437.60MUSD
$393.68MUSD
$377.35MUSD
$359.47MUSD
$339.22MUSD
$337.13MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.26MUSDP/E 9.7
$290.59MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$246.73MUSDP/E 12.3
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$202.91MUSD
$197.15MUSD
$187.92MUSDP/E 9.0
$175.54MUSD
$166.91MUSD
$143.51MUSDP/E 18.3
$132.34MUSD
$141.87MUSD
$128.15MUSD
$119.66MUSDP/E 18.6
$102.48MUSD
$85.39MUSDP/E 12.3
$93.61MUSD
$72.08MUSD
$65.22MUSD
$68.77MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$64.05MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$41.74MUSD
$46.21MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.40MUSD
$24.18MUSD
$23.84MUSDP/E 206.0
$23.98MUSD
$23.08MUSD
$22.15MUSD
$18.78MUSD
$18.30MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$13.96MUSD
$11.82MUSD
$11.45MUSD
$9.96MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$5.98MUSDP/E 0.2
$5.79MUSD
$5.46MUSDP/E Infinity
$1.93MUSD
$1.85MUSD
$1.85MUSDP/E 31.6
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap3.29M $
Enterprise Value64.83M $
Revenue (TTM)257.55M $
Gross Profit221.67M $
Net Income (TTM)35.64M $
Revenue/Share19.68 USD
Last Price0.5950 USD
Fiscal Year EndDec 2022
MR QuarterJun 2023
Employees134
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS2697961082
Valuation
P/E (Trailing)1.56
P/E (Forward)0.07
PEG—
EV/EBITDA1.04
EV/Revenue0.25
P/S0.01
P/B0.01
EPS (TTM)0.16
EPS (Forward)3.48
52W Range
0.001016% of range3.750
52W High3.750 USD
52W Low0.0010 USD
Profitability
Gross Margin70.01%
Oper. Margin15.94%
EBITDA Margin24.20%
Profit Margin11.26%
ROE15.26%
ROA8.78%
Growth
Revenue Growth-12.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.70M $
CapEx (TTM)178.00K $
FCF Margin14.88%
FCF Yield1164.80%
Net Debt57.10M $
Net Debt/EBITDA0.92
Balance Sheet
Debt/Equity0.27
Current Ratio2.16
Quick Ratio1.51
Book Value/Sh19.25 USD
Cash/Share1.182 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.16M
Float5.91M
Insiders0.00%
Institutions54.77%
Short Interest
Short Ratio3.9d
Short % Float4.19%
Short % Out.2.71%
Shares Short350.53K
Short (prev mo.)484.16K
Technical
SMA 500.5566 (+6.9%)
SMA 2000.6387 (-6.8%)
Beta0.63
S&P 52W Chg20.25%
Avg Vol (30d)11.54K
Avg Vol (10d)150
Technical Indicators
RSI (14)44.5
MACD0.0161
MACD Signal0.0307
MACD Hist.-0.0147
BB Upper0.7047 USD
BB Middle0.6412 USD
BB Lower0.5778 USD
BB Width19.80%
ATR (14)0.1534 USD
Vol Ratio (20d)0.02x